Sinclair, IS Pharma in talks to form pan-European specialty pharma company
It has been proposed that a merger be effected by way of an all-share offer by Sinclair Pharma (subject to the final terms and conditions of any offer)
WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.